Press Releases

Stay up-to-date on the latest information from OmegaQuant.

For media inquiries, please contact Becky Wright, Marketing Communications Director: becky@omegaquant.com

OmegaQuant Awarded NIH Grant to Investigate Fatty Acid Biomarkers for Age-Related Macular Degeneration (AMD) and Glaucoma

Read full release here.

First-Ever CDC NHANES Data Reveal Most Americans Have Low Omega-3 Levels

Read full release here.

Large UK Biobank Study Finds Higher Linoleic Acid Levels Linked to Lower Body Fat, Challenging Omega-6 Misconceptions

Read full release here.

New UK Biobank Analysis Links Higher Blood Linoleic Acid Levels With Lower Dementia Risk—While Other Omega-6 Fats Show the Opposite Pattern

Read full release here.

OmegaQuant to Showcase Personalized Omega-3 Solutions at the Integrative Healthcare Symposium 2026

Read full release here.

New Study Links Higher Omega-3 Levels to Lower Risk of Depression & Anxiety

Read full release here.

Large-Scale Study Shows Higher Blood Omega-3 Levels Linked to Lower Risk of Early-Onset Dementia Risk

Read full release here.

Higher Blood Omega-3 Levels Linked with Significantly Lower Atrial Fibrillation Risk

Read full release here.

New UK Biobank Study Links Higher Omega-3 Levels to Lower Risk of Self-Harm & Suicidal Ideation

Read full release here.

Speakers & Topics Announced for the 2nd Annual Fatty Acid Symposium

Read full release here.

New Study Links Blood Levels of Omega-3 Fatty Acids to Better Cognitive Health in People at Risk for Alzheimer’s Disease

Read full release here.


New Review of UK Biobank Data Reaffirms Broad Benefits of Fish Oil Use

Read full release here.

New Study Reveals Sharp Differences in Omega-3 Status Across Dietary Groups — Vegans Show Lowest Levels

Read full release here.

New Study Examining Blood Levels of Omega-6 in Thousands of Subjects Concludes that it Does Not Raise Inflammatory Markers

Read full release here.

ODS Recognizes Importance of Omega-3 DHA for Preterm and Early Preterm Birth Prevention

Read full release here.

Omega-3 Index, Smoking and Cholesterol Found to be Equal CVD Risk Predictors

Read full release here.

OmegaQuant Partners with FARI to Launch 1st Annual Fatty Acid Symposium

Read full release here.

New Study Shows Higher Omega-3 Levels Associated with Reduced Heart Failure Risk & Death

Read full release here.

New Fish Oil Research Makes Misleading Conclusions About Heart Risks

Read full release here.

New Paper Compares All Commercially Available Omega-3 Tests

Read full release here.

Study Shows Higher DHA Blood Levels Correlate Significantly with Longer Lifespan and Reduced Risk of Death from Cardiovascular Disease and Cancer

Read full release here.

Study Shows Omega-3 Index is Important for Improving Health Outcomes After a Heart Attack

Read full release here.

Study Shows People with a Higher Omega-3 Index Have a Lower Risk of Stroke

Read full release here.

OmegaQuant Awarded Grant to Develop Test that Predicts Dementia Risk

Read full release here.

OmegaQuant Awarded Grant to Develop Test that Predicts Metabolic Syndrome and Type 2 Diabetes by Analyzing Fatty Acid Profiles

Read full release here.

Study Shows Those with a Higher Omega-3 Index are More Protected from Severe COVID Infection

Read full release here.

Study Shows Middle-Aged Adults with a Low Omega-3 Index Have Smaller Brains that Have Aged Faster

Read full release here.

OmegaQuant Applauds ISSFAL Statement About the Relationship Between Omega-3 Blood Levels and Preterm Birth Risk

Read full release here.

OmegaQuant Launches HbA1c Test for People Looking to Manage & Monitor Their Blood Sugar Level

Read full release here.

OmegaQuant Launches New Test to Assess Vitamin B12 Status

Read full release here.

OmegaQuant Measures the Omega-3 Index of NBA Basketball Players

Read full release here.

OmegaQuant Launches Its Newest Nutritional Status Test — The Omega-3 Index for Pets

Read full release here.

Dr. Bill Harris, OmegaQuant Founder, and President of the Fatty Acid Research Institute Ranked Among Top 2% of Scientists Worldwide

Read full release here.

OmegaQuant Launches Vitamin D Test

Read full release here.

New Study Shows Omega-3 DHA Levels Are Inversely Related to Lung Disease

Read full release here.

OmegaQuant Makes Inc. 5000 List for 2nd Year in a Row & Continues to Blaze a Trail in Personalized Nutrition

Read full release here.

New Alzheimer’s Study Finds Using the Proper Dose of Omega-3 DHA is Key to Reaping Its Benefit

Read full release here.

OmegaQuant’s Dr. Bill Harris Named 2020 ASN Fellow

Read full release here.

OmegaQuant Partners with Standard Process to Offer the Omega-3 Index Test to Health Practitioners

Read full release here.

OmegaQuant Partners with Australia’s National Science Agency to Service APAC Region

Read full release here.

OmegaQuant Welcomes Omega-3 Blood Testing Statement from Major International Scientific Society

Read full release here.

Test Your Omega-3 Level for Free at FNCE 2019 & Learn About the Latest Omega-3 Studies

Read full release here.

OmegaQuant is the Official ‘Omega-3 Index Test Sponsor’ – Offering Free Testing at Vitafoods Asia 2019

Read full release here.

New Paper Creates Omega-3 Calculator For Researchers To Identify Proper EPA+DHA Doses in Studies

Read full release here.

OmegaQuant Makes Inc. 5000 List

Read full release here.

OmegaQuant Wins Award for the Prenatal DHA Initiative

Read full release here.

OmegaQuant’s Omega-3 Tests Now Registered in the EU

Read full release here.

Omega-3 Expert Supports New Research Showing that Omega-6 is Good for You

Read full release here.

New Research Shows People with PAD Could Have an Omega-3 Deficiency

Read full release here.

OmegaQuant Launches the First Prenatal DHA Blood Test for Pregnant Women

Read full release here.

More Fish Consumption and Omega-3 Supplementation Needed to Push the Omega-3 Index to 8%

Read full release here.

New Research Proposes Target DHA Level for Pregnant Women

Read full release here.

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.